Skip to main content

Grafa News and Videos — Page 1072

Grafa Headlines

Latest

Grafa

Rafael Holdings completes Phase 3 TransportNPC™ trial for Niemann-Pick Disease Type C

Rafael Holdings (NYSE:RFL) announced that the last patient has completed the final 96-week study visit in its pivotal Phase 3 TransportNPC™ trial evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C (NPC).

Read more: Rafael Holdings completes Phase 3 TransportNPC™ trial for Niemann-Pick Disease Type C

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift